Characterization of chronic cough patients participating in a phase 2b clinical trial of gefapixant, a P2X3 receptor antagonist

Authors
Category Primary study
JournalEUROPEAN RESPIRATORY JOURNAL
Year 2019
This article has no abstract
Epistemonikos ID: f998dcff7c5ce6bfaaef6b4082c8cf2cf249810e
First added on: Feb 11, 2025